Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebocontrolled dose-effect study November 13, 2003
Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia February 1, 2003
Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness January 1, 1999
Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action December 1, 1998
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis October 14, 1996
